Your browser doesn't support javascript.
loading
The societal burden of haemophilia A. III - The potential impact of emicizumab on costs of haemophilia A in Australia.
Brown, Laurie J; La, Hai A; Li, Jinjing; Brunner, Matthias; Snoke, Martin; Kerr, Annette M.
Affiliation
  • Brown LJ; NATSEM, Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, Australia.
  • La HA; NATSEM, Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, Australia.
  • Li J; NATSEM, Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, Australia.
  • Brunner M; Roche Products Pty Limited, Sydney, NSW, Australia.
  • Snoke M; Roche Products Pty Limited, Sydney, NSW, Australia.
  • Kerr AM; Roche Products Pty Limited, Sydney, NSW, Australia.
Haemophilia ; 26 Suppl 5: 21-29, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32935399

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Drug Costs / Cost of Illness / Antibodies, Bispecific / Antibodies, Monoclonal, Humanized / Hemophilia A Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Male Country/Region as subject: Oceania Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Drug Costs / Cost of Illness / Antibodies, Bispecific / Antibodies, Monoclonal, Humanized / Hemophilia A Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Male Country/Region as subject: Oceania Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United kingdom